Antiretroviral treatment outcomes among late HIV presenters initiating treatment with integrase inhibitors or protease inhibitors
Gundolf Schuettfort(Goethe University Frankfurt), AE Haberl(Goethe University Frankfurt), Gerrit Kann(Goethe University Frankfurt), Lisa Hamzah, Patrick Mallon(University College Dublin), Alfonso Cabello(Hospital Universitario Fundación Jiménez Díaz), Christoph Stephan(Goethe University Frankfurt), Philipp de Leuw(Goethe University Frankfurt), Timo Wolf(Goethe University Frankfurt), Jessica Doctor(Guy's and St Thomas' NHS Foundation Trust), Pavel Khaykin, Álvaro Mena(Universidade da Coruña), Eva Herrmann(Goethe University Frankfurt), Caroline Sabin(Primary Health Care), AG Cotter(University College Dublin), Miguel Górgolas(Hospital Universitario Fundación Jiménez Díaz), Marta del Palacio Tamarit(Hospital Universitario Fundación Jiménez Díaz), L Boekenkamp(Goethe University Frankfurt)
Cited by 15
Related Papers
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
|The Lancet|2014|930